[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:pkp2-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"PKP2 Gene",6,5,[8,16,22,28,34,40],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05885412","A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)",[12],"Phase 1","RECRUITING","2026-08-26T02:17:39.857430Z","2026-05-05T02:43:29.662378Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06228924","Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC",[12],"2026-08-26T02:16:42.787115Z","2026-05-05T02:43:26.923655Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06976606","A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM",[],"2026-08-26T02:18:32.765187Z","2026-05-13T02:55:06.603699Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT06644742","PKP2-ACM Natural History Study",[],"2026-08-26T02:17:19.710918Z","2026-05-13T02:55:06.559766Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT06311708","Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)",[],"2026-08-26T02:18:37.277498Z","2026-05-13T02:55:06.435017Z",{"nct_id":41,"title":42,"phases":43,"status":44,"updated_at":45,"content_modified":46},"NCT07050160","Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:54.044282Z","2026-06-16T05:54:07.850330Z"]